| . "Improved doubly robust estimation when data are monotonely coarsened, with application to longitudinal studies with dropout.." Biometrics. 2011;67(2):536-45. Pub Med |
| . "FLCRM: Functional linear Cox regression model.." Biometrics. 2018;74(1):109-117. Pub Med |
| . "Rejoinder to "A note on testing and estimation in marker-set association study using semiparametric quantile regression kernel machine".." Biometrics. 2018;74(2):767-768. Pub Med |
| . "A varying-coefficient generalized odds rate model with time-varying exposure: An application to fitness and cardiovascular disease mortality.." Biometrics. 2019;75(3):853-863. Pub Med |
| . "Bayesian spatial transformation models with applications in neuroimaging data.." Biometrics. 2013;69(4):1074-83. Pub Med |
| . "A global sensitivity test for evaluating statistical hypotheses with nonidentifiable models.." Biometrics. 2010;66(2):558-66. Pub Med |
| . "Additive mixed effect model for clustered failure time data.." Biometrics. 2011;67(4):1340-51. Pub Med |
| . "Multiple kernel learning with random effects for predicting longitudinal outcomes and data integration.." Biometrics. 2015;71(4):918-28. Pub Med |
| . "Bayesian design of biosimilars clinical programs involving multiple therapeutic indications.." Biometrics. 2020;76(2):630-642. Pub Med |
| . "Multiscale adaptive marginal analysis of longitudinal neuroimaging data with time-varying covariates.." Biometrics. 2012;68(4):1083-92. Pub Med |
| . "Bayesian influence measures for joint models for longitudinal and survival data.." Biometrics. 2012;68(3):954-64. Pub Med |
| . "Modeling survival distribution as a function of time to treatment discontinuation: A dynamic treatment regime approach.." Biometrics. 2018;74(3):900-909. Pub Med |
| . "Incorporating patient preferences into estimation of optimal individualized treatment rules.." Biometrics. 2018;74(1):18-26. Pub Med |
| . "Bayesian design of noninferiority trials for medical devices using historical data.." Biometrics. 2011;67(3):1163-70. Pub Med |
| . "A penalized likelihood approach for investigating gene-drug interactions in pharmacogenetic studies.." Biometrics. 2015;71(2):529-37. Pub Med |
| . "Estimating individualized treatment rules for ordinal treatments.." Biometrics. 2018;74(3):924-933. Pub Med |
| . "Inference for optimal dynamic treatment regimes using an adaptive m-out-of-n bootstrap scheme.." Biometrics. 2013;69(3):714-23. Pub Med |
| . "Spatial regression with covariate measurement error: A semiparametric approach.." Biometrics. 2016;72(3):678-86. Pub Med |
| . "Using decision lists to construct interpretable and parsimonious treatment regimes.." Biometrics. 2015;71(4):895-904. Pub Med |
| . "Bayesian path specific frailty models for multi-state survival data with applications.." Biometrics. 2015;71(3):760-71. Pub Med |
| . "Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome.." Biometrics. 2014;70(4):1003-13. Pub Med |
| . "Accelerated intensity frailty model for recurrent events data.." Biometrics. 2014;70(3):579-87. Pub Med |
| . "Semiparametric regression analysis of interval-censored competing risks data.." Biometrics. 2017;73(3):857-865. Pub Med |
| . "Outcome-dependent sampling with interval-censored failure time data.." Biometrics. 2018;74(1):58-67. Pub Med |
| . "Joint skeleton estimation of multiple directed acyclic graphs for heterogeneous population.." Biometrics. 2019;75(1):36-47. Pub Med |
| . "Biclustering via sparse clustering.." Biometrics. 2020;76(1):348-358. Pub Med |
| . "A unification of models for meta-analysis of diagnostic accuracy studies without a gold standard.." Biometrics. 2015;71(2):538-47. Pub Med |
| . "Probability-enhanced sufficient dimension reduction for binary classification.." Biometrics. 2014;70(3):546-55. Pub Med |
| . "Efficient estimation for accelerated failure time model under case-cohort and nested case-control sampling.." Biometrics. 2017;73(1):114-123. Pub Med |
| . "Partial correlation matrix estimation using ridge penalty followed by thresholding and re-estimation.." Biometrics. 2014;70(3):765-73. Pub Med |
| . "Response to reader reaction.." Biometrics. 2015;71(1):267-273. Pub Med |
| . "Analysis of secondary phenotypes in multigroup association studies.." Biometrics. 2020;76(2):606-618. Pub Med |
| . "A moment-adjusted imputation method for measurement error models.." Biometrics. 2011;67(4):1461-70. Pub Med |
| . "Detection of gene-gene interactions using multistage sparse and low-rank regression.." Biometrics. 2016;72(1):85-94. Pub Med |
| . "Factor selection and structural identification in the interaction ANOVA model.." Biometrics. 2013;69(1):70-9. Pub Med |
| . "Efficient semiparametric estimation of short-term and long-term hazard ratios with right-censored data.." Biometrics. 2013;69(4):840-9. Pub Med |
| . "A robust method for estimating optimal treatment regimes.." Biometrics. 2012;68(4):1010-8. Pub Med |
| . "Bayesian lasso for semiparametric structural equation models.." Biometrics. 2012;68(2):567-77. Pub Med |
| . "Fixed and random effects selection in mixed effects models.." Biometrics. 2011;67(2):495-503. Pub Med |
| . "Semiparametric estimation of the accelerated failure time model with partly interval-censored data.." Biometrics. 2017;73(4):1161-1168. Pub Med |
| . "Mixed model analysis of censored longitudinal data with flexible random-effects density.." Biostatistics. 2012;13(1):61-73. Pub Med |
| . "Multicategory reclassification statistics for assessing improvements in diagnostic accuracy.." Biostatistics. 2013;14(2):382-94. Pub Med |
| . "Sparse meta-analysis with high-dimensional data.." Biostatistics. 2016;17(2):205-20. Pub Med |
| . "Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial.." Biostatistics. 2011;12(2):258-69. Pub Med |
| . "Semiparametric inference for a 2-stage outcome-auxiliary-dependent sampling design with continuous outcome.." Biostatistics. 2011;12(3):521-34. Pub Med |
| . "Bayesian clinical trial design using historical data that inform the treatment effect.." Biostatistics. 2019;20(3):400-415. Pub Med |
| . "Characterizing expected benefits of biomarkers in treatment selection.." Biostatistics. 2015;16(2):383-99. Pub Med |
| . "Empirical pathway analysis, without permutation.." Biostatistics. 2013;14(3):573-85. Pub Med |
| . "Assessing the dependence of sensitivity and specificity on prevalence in meta-analysis.." Biostatistics. 2011;12(4):710-22. Pub Med |
| . "Checking semiparametric transformation models with censored data.." Biostatistics. 2012;13(1):18-31. Pub Med |
